U.S. Pharmaceutical Sales - Q3 2011

The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q3 2011. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.

Last updated: February 2014 (updated quarterly).

Top 100 Drugs for Q3 2011 by Sales

Rank Drug Sales ($000)
1 Lipitor
Pfizer Inc
1.05% Stats
2 Plavix
Bristol-Myers Squibb Company
-3.97% Stats
3 Nexium
AstraZeneca Pharmaceuticals, LP
-5.64% Stats
4 Abilify
Otsuka Pharmaceutical Co.
-1.34% Stats
5 Singulair
Merck & Co., Inc.
-4.34% Stats
6 (1) Seroquel
AstraZeneca Pharmaceuticals, LP
-2.15% Stats
7 (1) Advair Diskus
GlaxoSmithKline
-7.01% Stats
8 Crestor
AstraZeneca Pharmaceuticals, LP
-1.78% Stats
9 (3) Cymbalta
Eli Lilly and Company
6.08% Stats
10 Remicade
Centocor Ortho Biotech, Inc
1.52% Stats
11 (3) Humira
AbbVie, Inc.
3.95% Stats
12 (1) Enbrel
Amgen Inc.
1.27% Stats
13 (2) Zyprexa
Eli Lilly and Company
-4.04% Stats
14 (1) Neulasta
Amgen Inc.
-3.86% Stats
15 (6) Actos
Takeda Pharmaceuticals U.S.A., Inc
-11.05% Stats
16 Rituxan
Genentech, Inc (member of Roche group)
-1.77% Stats
17 (2) Copaxone
Teva Pharmaceuticals
-1.66% Stats
18 Lexapro
Forest Pharmaceuticals, Inc
-3.33% Stats
19 (2) OxyContin
-5.33% Stats
20 (2) Atripla
Gilead Sciences, Inc.
0.42% Stats
21 Avastin
Genentech, Inc (member of Roche group)
-3.57% Stats
22 (2) Epogen
Amgen Inc.
-13.96% Stats
23 Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc
-1.46% Stats
24 Januvia
Merck & Co., Inc.
1.19% Stats
25 (2) Truvada
Gilead Sciences, Inc.
1.15% Stats
26 Lantus
Sanofi (formerly Sanofi Aventis)
-3.61% Stats
27 (2) Diovan
Novartis Corporation
-9.44% Stats
28 (2) Lucentis
Genentech, Inc (member of Roche group)
1.13% Stats
29 Lyrica
Pfizer Inc
-2.94% Stats
30 (2) Celebrex
Pfizer Inc
-4.82% Stats
31 (1) Herceptin
Genentech, Inc (member of Roche group)
-0.64% Stats
32 (1) Diovan HCT
Novartis Corporation
-8.54% Stats
33 Avonex
Biogen Idec
-0.05% Stats
34 (2) Lantus Solostar
Sanofi (formerly Sanofi Aventis)
4.53% Stats
35 (2) Gleevec
Novartis Corporation
5.88% Stats
36 (2) Namenda
Forest Pharmaceuticals, Inc
-2.67% Stats
37 (2) OneTouch
-2.46% Stats
38 (1) enoxaparin
Generic
5.21% Stats
39 (16) Eloxatin
Sanofi (formerly Sanofi Aventis)
34.41% Stats
40 () Incivek
Vertex Pharmaceuticals
Stats
41 (2) Geodon
Pfizer Inc
3.81% Stats
42 TriCor
Abbott Laboratories
-0.32% Stats
43 (4) Suboxone
Reckitt Benckiser Pharmaceuticals Inc.
6.42% Stats
44 (4) Zetia
Merck & Co., Inc.
-7.20% Stats
45 (1) Vyvanse
Shire US Inc
1.08% Stats
46 Lidoderm
Endo Pharmaceuticals
-2.41% Stats
47 (3) Provigil
Cephalon, Inc. (a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd)
3.92% Stats
48 (29) Varivax
Merck & Co., Inc.
42.23% Stats
49 (4) Niaspan
Abbott Laboratories
-11.86% Stats
50 (1) AndroGel
AbbVie, Inc.
-5.89% Stats
51 (3) Aranesp
Amgen Inc.
-10.25% Stats
52 (31) methylphenidate
Generic
41.59% Stats
53 (12) Procrit
Janssen Pharmaceuticals, Inc
-21.61% Stats
54 (5) Rebif
1.48% Stats
55 (10) Seroquel XR
AstraZeneca Pharmaceuticals, LP
2.65% Stats
56 (1) Combivent
Boehringer Ingelheim Pharmaceuticals, Inc
-0.53% Stats
57 (9) amphetamine/dextroamphetamine
Generic
3.47% Stats
58 (5) Alimta
Eli Lilly and Company
1.37% Stats
59 (5) Viagra
Pfizer Inc
1.29% Stats
60 (1) Novolog
Novo Nordisk Inc.
-0.96% Stats
61 (7) Vytorin
Merck & Co., Inc.
-8.10% Stats
62 (9) Lovenox
Sanofi (formerly Sanofi Aventis)
-8.33% Stats
63 (4) Humalog
Eli Lilly and Company
-0.75% Stats
64 (4) Symbicort
AstraZeneca Pharmaceuticals, LP
-4.65% Stats
65 (5) Neupogen
Amgen Inc.
0.69% Stats
66 (8) ProAir HFA
Teva Pharmaceuticals
9.84% Stats
67 (9) Lovaza
GlaxoSmithKline
-8.96% Stats
68 (17) Nasonex
Merck & Co., Inc.
-14.77% Stats
69 (1) metoprolol
Generic
-4.57% Stats
70 (1) Reyataz
Bristol-Myers Squibb Company
-2.22% Stats
71 (9) Adderall XR
Shire US Inc
-12.77% Stats
72 (3) Flovent HFA
GlaxoSmithKline
-10.26% Stats
73 (17) Solodyn
Medicis Pharmaceutical Corporation
18.36% Stats
74 (1) fentanyl
Generic
-2.89% Stats
75 (3) Aciphex
Eisai Corporation
-6.32% Stats
76 (1) Levemir
Novo Nordisk Inc.
1.83% Stats
77 () Prevnar 13
Wyeth
Stats
78 (6) Isentress
Merck & Co., Inc.
6.05% Stats
79 (1) Cialis
Eli Lilly and Company
1.03% Stats
80 (6) NovoLog FlexPen
Novo Nordisk Inc.
4.15% Stats
81 (5) Lunesta
Sunovion Pharmaceuticals Inc.
-3.44% Stats
82 (4) Janumet
Merck & Co., Inc.
-2.60% Stats
83 (1) docetaxel
Generic
-2.92% Stats
84 (3) Evista
Eli Lilly and Company
-2.26% Stats
85 (10) budesonide
Generic
5.36% Stats
86 (2) Restasis
Allergan, Inc
-2.15% Stats
87 (2) Betaseron
Bayer Healthcare Pharmaceuticals
-2.89% Stats
88 (3) Zyvox
Pfizer Inc
-3.78% Stats
89 (5) Velcade
Takeda Pharmaceuticals U.S.A., Inc
2.42% Stats
90 (3) Erbitux
Bristol-Myers Squibb Company
-2.48% Stats
91 () Xeloda
Roche Pharmaceuticals
Stats
92 () Pradaxa
Boehringer Ingelheim Pharmaceuticals, Inc
Stats
93 (1) Benicar
Daiichi Sankyo
-5.94% Stats
94 () Opana ER
Endo Pharmaceuticals
Stats
95 (4) Synthroid
Abbott Laboratories
-0.04% Stats
96 (2) acetaminophen/hydrocodone
Generic
-0.90% Stats
97 (1) Zometa
-4.27% Stats
98 () Fluvirin
Stats
99 (2) VESIcare
Astellas Pharma US
-2.74% Stats
100 () Prezista
Janssen Pharmaceuticals, Inc
Stats

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Hide
(web1)